MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

Meeting: 2022 International Congress

Abstract Number: 362

Keywords: Hypokinesia, Parkinson’s, Scales

Category: Technology

Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease.

Background: Neurological disorders frequently manifest themselves through impairment, or loss, of facial expressions. Consequently, facial expression examination is a component of routine assessments such as the Movement Disorder Society (MDS) Unified PD Rating Scale (UPDRS) ​​[1]. Such assessments require rating by highly trained clinicians and take significant time to perform, making them unscalable and operator-dependent.

Method: We used markerless facial keypoints detection to extract biomarkers from videos (N=436) of routine assessments of Parkinson’s disease patients. Patients were rated by an experienced clinician on the UPDRS (0-4) at five separate clinical sites and recorded using commercially available mobile devices. Our derived set of features characterizes the general movement of the face as well as relates facial movements to emotions and facial muscles using Action Units (AUs). Two distinct parts of the UPDRS facial expression assessment, patient at rest and patient speaking, were considered separately. A machine learning model was then applied to provide an estimate of the severity as well as interpret the importance of individual features.

Results: Our model achieved 47.7% balanced accuracy for severity prediction with 72.6% accuracy in detecting impairment (Figure 1). Mapping of the features’ importance to facial keypoints indicates that eyes, brows, and mouth areas are the most important to estimation (Figure 2). This concurs with the MDS-UPDRS instructions.

Conclusion: Computer-assisted facial expression can provide cost-effective scalable routine assessments to patients with clear applications in telehealth. Moreover, this could be done using short video clips recorded using commercially available hardware.

feature importance

confusion matrix

References: ​​[1] Goetz, Christopher G., et al. “Movement Disorder Society sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.” Movement disorders: official journal of the Movement Disorder Society 23.15 (2008): 2129-2170.

To cite this abstract in AMA style:

Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe. Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/clinically-interpretable-severity-estimation-of-facial-expression-impairment-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinically-interpretable-severity-estimation-of-facial-expression-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley